Related Experiment Video
Updated: Jun 28, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA
Haotian Chen1,2, Jing Wen3, Wentao Zhang1,2
1Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Abstract:
Circular RNAs (circRNAs) play crucial biological functions in various tumors, including bladder cancer (BCa). However, the roles and underlying molecular mechanisms of circRNAs in the malignant proliferation of BCa are yet unknown. CircKDM1A was observed to be downregulated in BCa tissues and cells. Knockdown of circKDM1A promoted the proliferation of BCa cells and bladder xenograft growth, while the overexpression of circKDM1A exerts the opposite effect. The dual-luciferase reporter assay revealed that circKDM1A was directly bound to miR-889-3p, acting as its molecular sponge to downregulate CPEB3. In turn, the CPEB3 was bound to the CPE signal in p53 mRNA 3'UTR to stabilize its expression. Thus, circKDM1A-mediated CPEB3 downregulation inhibits the stability of p53 mRNA and promotes BCa malignant progression. In conclusion, circKDM1A functions as a tumor suppressor in the malignant proliferation of BCa via the miR-889-3p/CPEB3/p53 axis. CircKDM1A may be a potential prognostic biomarker and therapeutic target of BCa.
Insights
Circular RNAs (circRNAs) act as tumor suppressors in bladder cancer (BCa). CircKDM1A inhibits BCa proliferation by regulating the miR-889-3p/CPEB3/p53 pathway, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are implicated in various cancers, but their specific roles in bladder cancer (BCa) proliferation remain unclear.
- Understanding the molecular mechanisms of circRNAs in BCa is essential for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the function and molecular mechanism of circKDM1A in the malignant proliferation of bladder cancer.
- To explore the potential of circKDM1A as a biomarker and therapeutic target for BCa.
Main Methods:
- Quantitative real-time PCR to assess circKDM1A expression in BCa tissues and cells.
- Cell proliferation assays and xenograft models to evaluate the functional role of circKDM1A.
- Dual-luciferase reporter assays to confirm the interaction between circKDM1A, miR-889-3p, and CPEB3.
- Western blotting to analyze protein expression levels of CPEB3 and p53.
Main Results:
- CircKDM1A was found to be significantly downregulated in BCa tissues and cells.
- Knockdown of circKDM1A promoted BCa cell proliferation and tumor growth, while overexpression had the opposite effect.
- CircKDM1A acted as a molecular sponge for miR-889-3p, inhibiting CPEB3 expression.
- CPEB3 regulated p53 mRNA stability via the CPE signal in its 3'UTR, and circKDM1A-mediated CPEB3 downregulation reduced p53 stability, promoting BCa progression.
Conclusions:
- CircKDM1A functions as a tumor suppressor in bladder cancer by regulating the miR-889-3p/CPEB3/p53 signaling axis.
- CircKDM1A may serve as a potential prognostic biomarker and therapeutic target for bladder cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
MicroRNAs
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

